Theramex Ireland Limited

Poland

All drugs from this manufacturer

  • AIDEE

    The medicine is used for contraception (as an contraceptive pill) and for the treatment of moderate acne in women for whom topical treatment or antibiotics have not been effective.

    Dosage form: tablets, film-coated

    Active substance Dosage
    dienogest 2 mg
    ethinylestradiol 0.03 mg

    ATC: G03AA16

  • The medicine is used for the treatment of, among others, painful menstruation, endometriosis, irregular or excessively heavy periods, premenstrual syndrome, and infertility caused by low progesterone levels. It also helps to reduce the risk of miscarriage and alleviates menopause symptoms (HRT).

    Dosage form: tablets, film-coated

    Active substance Dosage
    dydrogesterone 10 mg

    ATC: G03DB01

  • The medicine is used for the treatment of, among others, painful menstruation, endometriosis, irregular or excessively heavy periods, premenstrual syndrome, and infertility related to low progesterone levels. It may also be used to reduce the risk of miscarriage or as part of hormone replacement therapy (HRT) for menopausal symptoms.

    Dosage form: tablets, film-coated

    Active substance Dosage
    dydrogesterone 10 mg

    ATC: G03DB01

  • The medicine is used for the treatment of, among other things, painful menstruation, endometriosis, irregular or excessively heavy periods, premenstrual syndrome, infertility, and to reduce the risk of miscarriage. It may also be used in Hormone Replacement Therapy (HRT) to alleviate menopause symptoms, such as hot flashes or night sweats.

    Dosage form: tablets, film-coated

    Active substance Dosage
    dydrogesterone 10 mg

    ATC: G03DB01

  • The medicine is used as part of hormone replacement therapy (HRT) to treat symptoms of estrogen deficiency in postmenopausal women.

    Dosage form: gel

    Active substance Dosage
    estradiol 0.1 %

    ATC: G03CA03

  • The medicine is used to relieve unpleasant menopausal symptoms (such as hot flashes, sleep disturbances, or vaginal atrophy) and for the prevention of osteoporosis, if the patient cannot take other medications.

    Dosage form: plaster, transdermal system

    Active substance Dosage
    estradiol 50 mcg/24 h

    ATC: G03CA03

  • The medicinal product is used to relieve unpleasant menopausal symptoms (such as hot flashes, sleep disturbances, or vaginal atrophy) and for the prevention of osteoporosis, if the patient cannot take other medicines for this purpose.

    Dosage form: plaster, transdermal system

    Active substance Dosage
    estradiol 50 mcg/24 h

    ATC: G03CA03

  • The medicinal product is used as hormone replacement therapy in women experiencing symptoms of estrogen deficiency (e.g., hot flashes) and where at least 6 months have passed since the last menstrual period. It may also be used to prevent osteoporosis in postmenopausal women who are at an increased risk of fractures.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 2 mg
    dydrogesterone 2 mg or 10 mg

    ATC: G03FB08

  • The medicine is used as hormone replacement therapy in women experiencing symptoms of estrogen deficiency (e.g., hot flashes) and who have not had a period for at least 6 months. It may also be used to prevent osteoporosis in postmenopausal women who are at an increased risk of fractures.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 2 mg
    dydrogesterone 2 mg or 10 mg

    ATC: G03FB08

  • The medicine is used as hormone replacement therapy in women with symptoms of estrogen deficiency (e.g., hot flashes), who have had no period for at least 6 months. It may also be used to prevent osteoporosis in postmenopausal women.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 2 mg
    dydrogesterone 2 mg or 10 mg

    ATC: G03FB08

  • The medicine is used as hormone replacement therapy in women experiencing symptoms of estrogen deficiency (e.g., hot flashes) and who have not had a menstrual period for at least 6 months. It may also be used to prevent osteoporosis in postmenopausal women.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 2 mg
    estradiol 2 mg
    dydrogesterone 10 mg

    ATC: G03FB08

  • The medicine is used as part of hormone replacement therapy to relieve menopausal symptoms (such as hot flashes) and to prevent osteoporosis in postmenopausal women who are at an increased risk of fractures.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 2 mg
    dydrogesterone 2 mg or 10 mg

    ATC: G03FB08

  • The medicinal product is used as hormone replacement therapy in women with symptoms of estrogen deficiency (e.g., hot flashes), who have not had a period for at least 6 months. It may also be used to prevent osteoporosis in postmenopausal women.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 2 mg
    dydrogesterone 2 mg or 10 mg

    ATC: G03FB08

  • The medicine is used as hormone replacement therapy in women experiencing symptoms of estrogen deficiency (e.g., hot flashes) and who have not had a period for at least 6 months. It may also be used to prevent osteoporosis in postmenopausal women.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 2 mg
    dydrogesterone 2 mg or 10 mg

    ATC: G03FB08

  • The medicine is used as hormone replacement therapy in women experiencing symptoms of estrogen deficiency (e.g., hot flashes) and where at least 6 months have passed since the last menstrual period. It may also be used to prevent osteoporosis in postmenopausal women.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 2 mg
    dydrogesterone 2 mg or 10 mg

    ATC: G03FB08

  • The medicine is used as hormone replacement therapy in women with symptoms of estrogen deficiency (e.g., hot flashes), who have not had a period for at least 6 months. It may also be used to prevent osteoporosis in postmenopausal women.

    Dosage form: tablets, film-coated

    ATC: G03FB08

  • The medicine is used as hormone replacement therapy in women experiencing symptoms of estrogen deficiency (e.g., hot flashes) and where at least 6 months have passed since their last period. It may also be used to prevent osteoporosis in postmenopausal women who are at an increased risk of fractures.

    Dosage form: tablets, film-coated

    ATC: G03FB08

  • The medicine is used as hormone replacement therapy in women experiencing symptoms of estrogen deficiency (e.g., hot flashes) and where at least 6 months have passed since their last period. It may also be used to prevent osteoporosis in postmenopausal women who are at an increased risk of fractures.

    Dosage form: tablets, film-coated

    ATC: G03FB08

  • The medicine is used in hormone replacement therapy in postmenopausal women (those who have had no period for at least 12 months) to relieve symptoms such as hot flashes (redness of the face, neck, and chest).

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 0.5 mg
    dydrogesterone 2.5 mg

    ATC: G03FA14

  • The medicine is used in hormone replacement therapy in postmenopausal women to relieve symptoms such as hot flashes (flushing of the face, neck, and chest).

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 0.5 mg
    dydrogesterone 2.5 mg

    ATC: G03FA14

  • The medicine is used in hormone replacement therapy in postmenopausal women to relieve symptoms such as hot flashes (redness of the face, neck, and chest).

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 0.5 mg
    dydrogesterone 2.5 mg

    ATC: G03FA14

  • The medicine is used in hormone replacement therapy in postmenopausal women to relieve symptoms such as hot flashes (redness of the face, neck, and chest).

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 0.5 mg
    dydrogesterone 2.5 mg

    ATC: G03FA14

  • The medicine is used as part of hormone replacement therapy in postmenopausal women to relieve symptoms of estrogen deficiency (e.g., hot flashes) and to prevent osteoporosis in women at increased risk of fractures.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 1 mg
    dydrogesterone 1 mg or 10 mg

    ATC: G03FB08

  • The medicine is used to treat symptoms occurring after menopause (such as hot flashes) and to prevent osteoporosis in postmenopausal women who are at an increased risk of fractures.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 1 mg
    dydrogesterone 1 mg or 10 mg

    ATC: G03FB08

  • The medicine is used in hormone replacement therapy in women with symptoms of estrogen deficiency (e.g., hot flashes), who have not had a period for at least 6 months. It may also be used to prevent osteoporosis in postmenopausal women if they cannot take other medicines.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 1 mg or 1 mg
    dydrogesterone 10 mg

    ATC: G03FB08

  • The medicine is used as part of hormone replacement therapy in women with symptoms of estrogen deficiency (e.g., hot flashes), who have not had a period for at least 6 months. It may also be used to prevent osteoporosis in postmenopausal women.

    Dosage form: tablets, film-coated

    Active substance Dosage
    estradiol 1 mg
    dydrogesterone 1 mg + 10 mg

    ATC: G03FB08

  • This is a contraceptive tablet used to prevent pregnancy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    drospirenone 3 mg
    ethinylestradiol 0.03 mg

    ATC: G03AA12

  • This is a contraceptive tablet used to prevent pregnancy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    drospirenone 3 mg
    ethinylestradiol 0.03 mg

    ATC: G03AA12

  • It is a contraceptive tablet used to prevent pregnancy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    drospirenone 3 mg
    ethinylestradiol 0.02 mg

    ATC: G03AA12

  • It is a contraceptive tablet used to prevent pregnancy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    drospirenone 3 mg
    ethinylestradiol 0.02 mg

    ATC: G03AA12

  • It is a contraceptive agent used to prevent pregnancy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    drospirenone 3 mg
    ethinylestradiol 0.02 mg

    ATC: G03AA12

  • It is a contraceptive used to prevent pregnancy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    drospirenone 3 mg
    ethinylestradiol 0.02 mg

    ATC: G03AA12

  • It is a contraceptive used to prevent pregnancy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    drospirenone 3 mg
    ethinylestradiol 0.02 mg

    ATC: G03AA12

  • It is a contraceptive used to prevent pregnancy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    drospirenone 3 mg
    ethinylestradiol 0.02 mg

    ATC: G03AA12

  • The medicine is used to correct progesterone deficiencies. In premenopausal women, it helps with menstrual disorders (e.g., infrequent or very frequent periods, absence of menstruation), genital bleeding, and premenstrual symptoms (e.g., painful menstruation, breast tenderness). In postmenopausal women, it is used as part of hormone replacement therapy.

    Dosage form: tablets

    ATC: G03DB04